What quality control measures does Sanofi implement?

Sanofi takes quality control very seriously and implements a comprehensive array of measures to ensure that its products meet high standards of safety, efficacy, and quality. Quality control begins during the research and development phase, where Sanofi utilizes rigorous testing and evaluation protocols to assess the performance of new drugs and vaccines. These protocols include preclinical studies followed by a series of clinical trials that require substantial oversight and compliance with regulatory standards. Once products move into production, Sanofi ensures that manufacturing facilities maintain strict adherence to Good Manufacturing Practices (GMP). This includes continuous monitoring of the manufacturing process, as well as conducting regular inspections and audits to ensure compliance with these standards. The company employs a variety of analytical methods to perform in-process testing, confirming that each stage of production meets established quality criteria. Additionally, Sanofi has robust systems in place for batch release, ensuring that only products that pass all quality testing are distributed to the market. Post-market surveillance is also a crucial part of Sanofi's quality control strategy. This involves ongoing monitoring of products once they are available to the public, allowing for the identification of any emerging safety issues or quality concerns. For more detailed information on specific quality control measures, interested individuals may find it helpful to visit the Sanofi website to explore their current resources.